Cart
sales@molnova.com
Vardenafil hydrochloride
CAS No. 224785-91-5
Vardenafil hydrochloride ( —— )
Catalog No. M21601 CAS No. 224785-91-5
Vardenafil hydrochloride is a New Phosphodiesterase Type 5(PDE5) Inhibitor in the Treatment of Erectile Dysfunction in Men With Diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 61 | Get Quote |
|
| 200MG | 113 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVardenafil hydrochloride
-
NoteResearch use only not for human use.
-
Brief DescriptionVardenafil hydrochloride is a New Phosphodiesterase Type 5(PDE5) Inhibitor in the Treatment of Erectile Dysfunction in Men With Diabetes.
-
DescriptionVardenafil hydrochloride is a New Phosphodiesterase Type 5(PDE5) Inhibitor in the Treatment of Erectile Dysfunction in Men With Diabetes.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE5
-
Research AreaMetabolic Disease
-
IndicationErectile Dysfunction
Chemical Information
-
CAS Number224785-91-5
-
Formula Weight525.06
-
Molecular FormulaC23H33ClN6O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (190.45 mM; Need ultrasonic); H2O:100 mg/mL (190.45 mM)
-
SMILESCl.CCCc1nc(C)c2n1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Irwin Goldstein Jay M Young Jerome Fischer.Vardenafil a New Phosphodiesterase Type 5 Inhibitor in the Treatment of Erectile Dysfunction in Men With Diabetes: A Multicenter Double-Blind Placebo-Controlled Fixed-Dose Study.Diabetes Care. 2003 Mar;26(3):777-83.
molnova catalog
related products
-
Roflumilast
Roflumilast is a phosphodiesterase-4 (PDE-4) inhibitor.
-
Zaprinast
Zaprinast (M&B 22948) is a potent, cGMP-specific phosphodiesterase inhibitor with IC50 of 0.5-0.76 and 0.15 uM for PDE5 and PDE6 respectively.
-
GSK 256066 Trifluoro...
A potent, selective PDE4 inhibitor with pIC50 of 11.5, 11.3, 11.4, and 11.9 for PDE4B, A, C, and D, respectively.
